B7-H4 and PD-L1 (PD-1 ligand), as inhibitory immune checkpoints, are often exploited by cancer cells to evade immunosurveillance in OSCC 36 and have been proven to be prognostic biomarkers in OSCC 37, 38. This evidence concerns the gene VTCN1 and cancer.